Home/Filings/4/0001209191-22-062832
4//SEC Filing

Metcalfe David A 4

Accession 0001209191-22-062832

CIK 0000708818other

Filed

Dec 27, 7:00 PM ET

Accepted

Dec 28, 4:14 PM ET

Size

11.0 KB

Accession

0001209191-22-062832

Insider Transaction Report

Form 4
Period: 2022-12-27
Metcalfe David A
Chief Technology Officer
Transactions
  • Tax Payment

    Common Stock

    2022-12-27$18.95/sh4,257$80,670178,207 total
  • Exercise/Conversion

    Common Stock

    2022-12-27+42,215203,394 total
  • Tax Payment

    Common Stock

    2022-12-27$18.95/sh20,930$396,624182,464 total
  • Exercise/Conversion

    Performance Stock Units

    2022-12-2742,2150 total
    Common Stock (42,215 underlying)
Footnotes (4)
  • [F1]Performance stock units convert to shares of NXGN common stock on a one-for-one basis once fully vested.
  • [F2]Represents shares withheld to satisfy tax withholding obligations on the vesting of performance stock units.
  • [F3]Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock.
  • [F4]On December 27, 2022, 42,215 performance stock units vested for the reporting person based on the Company's achievement of fiscal year 2021 and 2022 revenue goals and modified for 3-year total shareholder return ("TSR") performance for the period December 26, 2019 through December 27, 2022.

Issuer

NEXTGEN HEALTHCARE, INC.

CIK 0000708818

Entity typeother

Related Parties

1
  • filerCIK 0001664295

Filing Metadata

Form type
4
Filed
Dec 27, 7:00 PM ET
Accepted
Dec 28, 4:14 PM ET
Size
11.0 KB